-transparent.png){kind=logo}
Thyroid-stimulating immunoglobulins (TSI) have been detected by receptor assay in the sera of 43% of patients with ophthalmic Graves' disease. Comparison of the receptor assay studies with thyroid function tests indicated that in several patients the antibodies detected by receptor assay were biologically inactive. In other patients, thyroid function appeared to be under TSI control with hyperthyroidism prevented by autoimmune destruction of the thyroid.
Related Publications
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
August 1974,
Lancet (London, England),
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
October 1986,
Medicina clinica,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
November 1984,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
January 1983,
Acta endocrinologica. Supplementum,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
November 2011,
Ophthalmology,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
March 1986,
Acta endocrinologica,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
August 1981,
Clinical endocrinology,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
January 2006,
Endokrynologia Polska,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
December 1980,
The Journal of clinical endocrinology and metabolism,
C S Teng, and
B R Smith, and
B Clayton, and
D C Evered, and
F Clark, and
R Hall
February 2022,
Thyroid : official journal of the American Thyroid Association,
